These findings support our prediction that, in these mice, Rb1 modulates gut microbiota to regulate the synthesis and decomposition of phosphatidylcholine in glycerophospholipid metabolism, which in turn decreases serum TC, suppressing hyperlipidemia (Figure 5). This evidence concerns the gene RB1 and hyperlipidemia.